0.1624
0.00495 (3.14%)
0.00495 (3.14%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| IntelliPharmaCeutics International Inc (QB) | IPCIF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00495 | 3.14% | 0.1624 | 16:00:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.16 | 0.15 | 0.1624 | 0.1624 | 0.15745 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.144 | 0.173 | 0.029 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12 | 103,801 | $ 0.159265 | $ 16,532 | - | 0.058 - 0.7099 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:04:21 | 1 | $ 0.155 | USD |
IntelliPharmaCeutics (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.77M | 23.20M | - | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 6.21k | $ - | 0.00% | - | - |
IntelliPharmaCeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IPCIF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.16 | 0.1746 | 0.14 | 0.1604136 | 82,078 | 0.0024 | 1.5% |
| 1 Month | 0.136 | 0.1746 | 0.11 | 0.1516079 | 70,551 | 0.0264 | 19.41% |
| 3 Months | 0.1768 | 0.1881 | 0.11 | 0.1480056 | 41,601 | -0.0144 | -8.14% |
| 6 Months | 0.1497 | 0.262218 | 0.0588 | 0.1473533 | 38,253 | 0.0127 | 8.48% |
| 1 Year | 0.64 | 0.7099 | 0.058 | 0.186182 | 65,733 | -0.4776 | -74.63% |
| 3 Years | 0.1656 | 1.50 | 0.058 | 0.3345186 | 114,590 | -0.0032 | -1.93% |
| 5 Years | 0.1656 | 1.50 | 0.058 | 0.3345186 | 114,590 | -0.0032 | -1.93% |
IntelliPharmaCeutics (QB) Description
| Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals. Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company's abuse-deterrent oxycodone hydrochloride extended release formulation ("Oxycodone ER") based on its proprietary nPODDDS novel Point Of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). |
